-
Flex Pharma Could Still Double From Here, Roth Analyst Says
Wednesday, January 6, 2016 - 2:02pm | 136Shares of Flex Pharma Inc (NASDAQ: FLKS) have lost 19 percent of value over the past year, but Joseph Pantginis of Roth Capital Partners is estimating the stock could double in value from its current valuation. Pantginis noted that following the completion of enrollment in the NLC study suing the...
-
IPO Outlook: Shake Shack IPO Set To Wrap Up Busy Week
Tuesday, January 27, 2015 - 8:25am | 1297Shake Shack (NYSE: SHAK) will be this week’s highlight IPO if its 5 million-share offering raises the expected $92 million in proceeds. With a price between $14 and $16, the company will be valued at nearly $570 million. Shake Shack describes itself as “a modern day '...